Skip to main content
. 2025 Sep 12;11(9):735. doi: 10.3390/gels11090735
BMP-2 Human bone morphogenetic protein 2
CH–GA Chitosan-glycolic acid
CLM Chitosan-based luminescent/magnetic
CMAs Myristic acid and chitosan-based nanogels
CMC Carboxymethyl chitosan
CMCS Carboxymethyl chitosan
CS-g Chitosan grafted
DD Degree of deacetylation
DMA 2,3-dimethylmaleic anhydride
DNA Deoxyribonucleic acid
EMA European Medicine Agency
FDA Food and Drug Administration
GMP Good Manufacturing Practices
LCST Lower critical solution temperature
MA-CMCs Methacrylic anhydride-modified carboxymethyl chitosan
mRNAs Messenger RNAs
MW Molecular weight
NAR/β-CD Naringenin–β-cyclodextrin
NG Nanogel
NLG Nanolipogel
OPs Oyster peptide
PCL Polycaprolactone
PCS Phosphorylated chitosan
PEG Polyethylene glycol
PNIPAAm Poly(N-isopropylacrylamide)
PVA Polyvinyl alcohol
QbD Quality-by-design
recNcPDI Nanogel-encapsulated recombinant NcPDI
RNAi RNA interference
RT-PCR Reverse transcription polymerase chain reaction
siRNA Small interfering RNA
TALENs Transcription activator-like effector nucleases
TC Trimethyl chitosan-cysteine
TPP Tripolyphosphate
Tyr Tyrosine
uPA Urokinase-type plasminogen activator
ZFNs Zinc finger nucleases